ERCC6-PGBD3
ercc6-pgbd3: A Gene Implicated in Cancer and Neurodegenerative Diseases
Description
The ercc6-pgbd3 gene, also known as excision repair cross-complementing rodent repair deficiency, complementation group 6 (ERCC6), is a key player in the nucleotide excision repair (NER) pathway. This pathway is responsible for repairing DNA damage caused by ultraviolet radiation (UV) and certain chemicals.
ERCC6 encodes a protein that interacts with the ERCC8-XPF endonuclease complex, which plays a crucial role in removing damaged DNA segments during the NER process. Mutations in the ercc6-pgbd3 gene can impair NER and increase the risk of developing cancer and neurodegenerative diseases.
Associated Diseases
Cancer: Studies have associated ercc6-pgbd3 mutations with an increased risk of various types of cancer, including:
- Skin cancer (melanoma and non-melanoma)
- Lung cancer
- Ovarian cancer
- Bladder cancer
- Head and neck cancer
Neurodegenerative diseases: Mutations in ercc6-pgbd3 have also been linked to an increased risk of neurodegenerative diseases, such as:
- Alzheimer's disease
- Parkinson's disease
- Amyotrophic lateral sclerosis (ALS)
Did you Know ?
According to the National Cancer Institute, individuals with ercc6-pgbd3 mutations are at a 2-fold higher risk of developing skin cancer compared to the general population.
